@article{Tameris:153114,
      author        = "Tameris, Michele and Rozot, Virginie and Imbratta, Claire
                       and Geldenhuys, Hennie and Mendelsohn, Simon C. and Kany
                       Luabeya, Angelique Kany and Shenje, Justin and Tredoux,
                       Nicolette and Fisher, Michelle and Mulenga, Humphrey and
                       Bilek, Nicole and Young, Carly and Veldsman, Ashley and
                       Botes, Natasja and Thole, Jelle and Fritzell, Bernard and
                       Mukherjee, Rajat and Jelsbak, Ingrid Murillo and Rodriguez,
                       Esteban and Puentes, Eugenia and Doce, Juana and Marinova,
                       Dessislava and Gonzalo-Asensio, Jesús and Aguilo, Nacho
                       and Martin, Carlos and Scriba, Thomas J. and Hatherill,
                       Mark and Abrahams, Charmaine and Africa, Hadn and Arendsen,
                       Denis and Barnard, Liezl and Cloete, Yolundi and Davids,
                       Ilse and Erasmus, Mzwandile and Filander, Elizabeth and
                       Gregg, Yolande and Herling, Roxane and Jansen, Ruwiyda and
                       Jack, Lungisa and Kelepu, Xoliswe and Kyepa, Henriette and
                       Leopeng, Thelma and Mabwe, Simbarahse and Mactavie, Lauren
                       and Makhete, Lebohang and Mangali, Sandisiwe and Mouton,
                       Angelique and Nkambule, Hlengiwe and Noble, Julia and
                       Nombida, Onke and Nqakala, Nambitha and Opperman, Fajwa and
                       Raphela, Rodney and Rossouw, Susan and Schoeman, Elisma and
                       Schreuder, Constance and Steyn, Marcia and Swanepoel,
                       Liticia and Toefy, Asma and Tromp, Anele and Tyambethu,
                       Petrus and Valley, Habibullah and Van Rooyes, Johanna",
      title         = "{Safety, reactogenicity, and immunogenicity of MTBVAC in
                       infants: a phase 2a randomised, double-blind, dose-defining
                       trial in a TB endemic setting}",
      year          = "2025",
}